180 Neb. Admin. Code, ch. 7, § 002

Current through September 17, 2024

Section 180-7-002 - DEFINITIONS

As used in 180 NAC 7, the following definitions apply to this chapter:

002.01ACCREDITED INSTITUTION. A teaching facility for nuclear medicine technology or radiation therapy technology whose standards are accepted by the United States Department of Education.

002.02ADDRESS OF USE. The address of the building or buildings identified on the license and where radioactive material may be produced, prepared, received, used, or stored.

002.03AREA OF USE. The portion of an address of use set aside for the purpose of receiving, using, or storing radioactive material.

002.04ASSOCIATE RADIATION SAFETY OFFICER (ARSO). An individual who:

(A) Meets the requirements in 180 NAC 7-022 and 7-027; and

(B) Is currently identified as an (ARSO) for the types of use of radioactive material for which the individual has been assigned duties and tasks by the (RSO) on:

(i) A specific medical use license issued by the Department, the U.S. Nuclear Regulatory Commission (NRC), or an Agreement State; or

(ii) A medical use permit issued by an U.S. Nuclear Regulatory Commission (NRC) master material licensee.

002.05AUTHORIZED MEDICAL PHYSICIST. An individual who:

(A) Meets the requirements in 180 NAC 7-023(A) and 7-027; or

(B) Is identified as an authorized medical physicist or teletherapy physicist on a specific license or equivalent permit issued by the Department, NRC or Agreement State; or

(C) Is identified as an authorized medical physicist on a permit issued by a Department, NRC, or Agreement State specific medical use license of broad scope authorized to permit the use of radioactive material.

002.06AUTHORIZED NUCLEAR PHARMACIST. A pharmacist who:

(A) Meets the requirements of 180 NAC 7-024.01 and 7-027; or

(B) Is identified as an authorized nuclear pharmacist on a specific license or equivalent permit that authorizes medical use, the practice of nuclear pharmacy, commercial nuclear pharmacy or the manufacture and distribution of radiopharmaceuticals issued by the Department, NRC or Agreement State; or

(C) Is identified as an authorized nuclear pharmacist on a permit issued by the Department, NRC or Agreement State specific medical use license of broad scope authorized to permit the use of radioactive material.

002.07AUTHORIZED USER. A physician, dentist, or podiatrist who:

(A) Meets the requirements in 180 NAC 7-027 and 7-043(A), 7-047.01, 7-052.(A), 7-053.(A), 7-054.(A), 7-063.(A), 7-066.(A) or 7-084.(A); or

(B) Is identified as an authorized user on a specific license or equivalent permit issued by the Department, NRC or Agreement State; or

(C) Is identified as an authorized user on a permit issued by an Department, NRC or Agreement State specific license of broad scope authorized to permit the medical use of radioactive material.

002.08BRACHYTHERAPY. A method of radiation therapy where plated, embedded, activated, or sealed sources are utilized to deliver a radiation dose at a distance of up to a few centimeters, by surface, intracavitary, intraluminal, or interstitial application.

002.09BRACHYTHERAPY SOURCE. A radioactive source or a manufacturer-assembled source train or a combination of these sources designed to deliver a therapeutic dose within a distance of a few centimeters.

002.10CLIENT'S ADDRESS. The address of use or a temporary job site for the purpose of providing mobile medical service according to 180 NAC 7-038.

002.11DEDICATED CHECK SOURCE. A radioactive source used to assure the consistent response of a radiation detection or measurement device over several months or years.

002.12DIAGNOSTIC CLINICAL PROCEDURES MANUAL. A collection of written procedures that describes each method, and other instructions and precautions, by which the licensee performs diagnostic clinical procedures; where each diagnostic clinical procedure has been approved by the authorized user and includes the radiopharmaceutical, dosage, and route of administration, or in the case of sealed sources for diagnosis, the procedure.

002.13HIGH DOSE-RATE (HDR) REMOTE AFTER LOADER. A device that remotely delivers a dose rate in excess of 12 gray (1200 rads) per hour at the treatment site.

002.14LOW DOSE-RATE (LDR) REMOTE AFTERLOADER. A device that remotely delivers a dose rate of less than or equal to 2 gray (200 rads) per hour at the treatment site.

002.15MANAGEMENT. The individual having the authority to manage, direct, or administer the licensee's activities, or that persons' designee or designees.

002.16MANUAL BRACHYTHERAPY. A type of therapy where the brachytherapy sources are manually applied or inserted.

002.17MEDICAL INSTITUTION. An organization where several medical disciplines are practiced.

002.18MEDICAL USE. The intentional internal or external administration of radioactive material, or radiation from radioactive material to patients or human research subjects under the supervision of an authorized user.

002.19MEDIUM DOSE-RATE (MDR) REMOTE AFTERLOADER . A brachytherapy device that remotely delivers a dose rate of greater than 2 gray (200 rads) per hour, but less than 12 gray (1200 rads) per hour at the point or surface where the dose is prescribed.

002.20MISADMINISTRATION. An event that meets the criteria in 180 NAC 7-115.

002.21MOBILE MEDICINE SERVICE. The transportation of radioactive material or its medical use at the client's address.

002.22NUCLEAR MEDICINE TECHNOLOGIST. An individual who meets the requirements of 180 NAC 7-025.01 and is under the supervision of an authorized user, to prepare or administer radioactive drugs to patients or human research subjects, or perform in vivo or in vitro measurements for medical purposes.

002.23NUCLEAR MEDICINE TECHNOLOGY. The science and art of in vivo or in vitro detection and measurement of radioactivity and the administration of radioactive drugs to patients or human research subjects for diagnostic and therapeutic purposes.

002.24OPHTHALMIC PHYSICIST. An individual who:

(A) Meets the requirements in 180 NAC 7-060.05 and 180 NAC 7-027; and

(B) Is identified as an ophthalmic physicist on a:

(i) Specific medical use license issued by the Department, NRC or an Agreement State;

(ii) Permit issued by a Department, NRC or Agreement State broad scope medical use licensee;

(iii) Medical use permit issued by a NRC master material licensee; or

(iv) Permit issued by a NRC master material licensee broad scope medical use permittee.

002.25OUTPUT. The exposure rate, dose rate, or a quantity related in a known manner to these rates from a brachytherapy source or a teletherapy, remote afterloader, or gamma stereotactic radiosurgery unit for a specified set of exposure conditions.

002.26PATIENT INTERVENTION. Actions by the patient or human research subject, whether intentional or unintentional, dislodging or removing treatment devices or prematurely terminating the administration.

002.27PRECEPTOR. An individual who provides, directs, or verifies training and experience required for an individual to become an authorized user, authorized medical physicist, authorized nuclear pharmacist, nuclear medicine technologist, radiation therapy technologist, RSO, or ARSO.

002.28PRESCRIBED DOSAGE. A specified activity or range of activity of radioactive drug as documented:

(A) In a written directive as specified in 180 NAC 7-019; or

(B) According to the directions of the authorized user for procedures performed per 180 NAC 7-041, 7-044 and 7-048.

002.29PRESCRIBED DOSE. A prescribed dose means for:

(A) Gamma stereotactic radiosurgery, the total dose as documented in the written directive;

(B) Teletherapy, the total dose and dose per fraction as documented in the written directive;

(C) Manual brachytherapy, either the total source strength and exposure time or the total dose as documented in the written directive; or

(D) Remote brachytherapy afterloaders, the total dose and dose per fraction as documented in the written directive.

002.30PULSED DOSE-RATE (PDR) REMOTE AFTERLOADER . A special type of remote afterloading device that uses a single source capable of delivering dose rates in the "high dose-rate" range, but is:

(A) Approximately one-tenth of the activity of typical HDR remote afterloader sources; and

(B) Used to simulate the radiobiology of a LDR treatment by inserting the source for a given fraction of each hour.

002.31RADIATION SAFETY OFFICER (RSO). An individual who:

(A) Meets the requirements in 180 NAC 7-022.01 and 7-026;

(B) Is identified as RSO on an NRC or Agreement State license or other equivalent permit or license recognized by the Department for similar types and uses of radioactive material.

002.32RADIATION THERAPIST. An individual who meets the requirements of 180 NAC 7-025.02 and is under the supervision of an authorized user to perform procedures and apply radiation emitted from sealed radioactive sources to human beings for therapeutic purposes.

002.33RADIATION THERAPY TECHNOLOGY. The science and art of applying radiation emitted from sealed radioactive sources to patients or human research subjects for therapeutic purposes.

002.34RADIOACTIVE DRUG. Any chemical compound containing radioactive material that may be used on or administered to patients or human research subjects as an aid in the diagnosis, treatment, or prevention of disease or other abnormal condition.

002.35SEALED SOURCE AND DEVICE REGISTRY. A national registry that contains all the registration certificates maintained by the NRC that summarize the radiation safety information for the sealed sources and devices and describe the licensing and use conditions approved for the product.

002.36STEREOTACTIC RADIOSURGERY. The use of external radiation in conjunction with a stereotactic guidance device to precisely deliver a dose to a treatment site.

002.37STRUCTURED EDUCATION PROGRAM. An educational program designed to impart particular knowledge and practical education through interrelated studies and supervised training.

002.38TELETHERAPY. A method of radiation therapy where collimated gamma rays are delivered at a distance from the patient or human research subject.

002.39TEMPORARY JOB SITE. A location where mobile medical services are conducted other than any location of use authorized on the license.

002.40THERAPEUTIC DOSAGE. A radiation dosage of unsealed radioactive material intended to deliver a radiation dose to a patient or human research subject for palliative or curative treatment.

002.41THERAPEUTIC DOSE. A radiation dose delivered from a source containing radioactive material to a patient or human research subject for palliative or curative treatment.

002.42TREATMENT SITE. An anatomical description of the tissue intended to receive a radiation dose, as described in a written directive.

002.43TYPE OF USE. The use of radioactive material as specified in 180 NAC 7-041, 7-044, 7-048, 7-055, 7-065, 7-067 or 7-085.

002.44UNIT DOSAGE. A dosage that is:

(A) Obtained or prepared according to the regulations for uses described in 180 NAC 7-041, 7-044, or 7-048; and

(B) To be administered as a single dosage to patient or human research subject without any further manipulation of the dosage after it is initially prepared.

002.45WRITTEN DIRECTIVE. An authorized user's written order for the administration of a radioactive material or radiation from radioactive material to a specific patient or human research subject, as specified in 180 NAC 7-019.

180 Neb. Admin. Code, ch. 7, § 002

Amended effective 11/3/2020

Amended effective 6/14/2023